Hazarapetyan Lusine, Zelveian Parounak, Hayrapetyan Hamlet, Grigoryan Svetlana
Department of Cardiology, Yerevan State Medical University, Yerevan, Armenia.
Department of Cardiology, "Yerevan" MRC, Yerevan, Armenia.
J Clin Med Res. 2024 Dec;16(11):547-553. doi: 10.14740/jocmr6108. Epub 2024 Nov 30.
Heart failure (HF) is often accompanied by atrial fibrillation (AF), which significantly worsens the outcome of both diseases. Half of individuals with HF has AF, and HF occurs in more than one-third of individuals with AF. Thus, HF and AF are commonly encountered together and are closely interrelated with similar risk factors. The aim of this study was to investigate the impact of potential risk factors on the occurrence of paroxysmal/persistent AF in patients with heart failure with moderately reduced ejection fraction (HFmrEF).
The study included 193 patients with HFmrEF and nonvalvular paroxysmal/persistent AF after successful cardioversion. As a control group the similar 76 patients without AF were examined. All patients underwent the examination, including electrocardiography (ECG), echocardiography, ambulatory blood pressure monitoring and Holter ECG monitoring. Levels of inflammatory markers, such as high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and the fibrotic marker transforming growth factor-β1 (TGF-β1) were measured using the enzyme-linked immunosorbent assay (ELISA) method. The obtained results were modeled using binary logistic regression using the odds ratio (OR).
It was shown that frequent episodes of hypertensive crisis (HC) and increased body mass index (BMI) were possible risk factors for paroxysmal/persistent AF. An increased OR of diastolic and systolic parameters of the left ventricle was associated with significant atrial and ventricular remodeling. Statistically, higher OR of inflammatory markers levels, such as hs-CRP, IL-6 and TNF-α were associated with an increased risk of paroxysmal/persistent AF occurrence in HFmrEF patients compared to similar patients without AF. An increase of the fibrosis marker TGF-β1 OR was statistically significant in patients with persistent AF.
It could be considered that frequency of HC, BMI, atrial and ventricular remodeling, as well as an increase of inflammation markers were possible risk factors for the occurrence of paroxysmal/persistent AF in HFmrEF patients. Moreover, fibrosis factor level significantly increased the likelihood of persistent AF in these patients.
心力衰竭(HF)常伴有心房颤动(AF),这会显著恶化两种疾病的预后。一半的心力衰竭患者患有心房颤动,而超过三分之一的心房颤动患者会发生心力衰竭。因此,心力衰竭和心房颤动经常同时出现,并且与相似的危险因素密切相关。本研究的目的是调查潜在危险因素对射血分数中度降低的心力衰竭(HFmrEF)患者阵发性/持续性心房颤动发生的影响。
该研究纳入了193例成功复律后患有HFmrEF和非瓣膜性阵发性/持续性心房颤动的患者。作为对照组,检查了76例无房颤的类似患者。所有患者均接受了检查,包括心电图(ECG)、超声心动图、动态血压监测和动态心电图监测。使用酶联免疫吸附测定(ELISA)方法测量炎症标志物水平,如高敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和纤维化标志物转化生长因子-β1(TGF-β1)。使用比值比(OR)通过二元逻辑回归对获得的结果进行建模。
结果表明,高血压危象(HC)频发和体重指数(BMI)增加可能是阵发性/持续性心房颤动的危险因素。左心室舒张和收缩参数的OR值增加与显著的心房和心室重构相关。从统计学上讲,与无房颤的类似患者相比,HFmrEF患者中hs-CRP、IL-6和TNF-α等炎症标志物水平的OR值较高与阵发性/持续性心房颤动发生风险增加相关。纤维化标志物TGF-β1的OR值在持续性房颤患者中增加具有统计学意义。
可以认为,HC的频率、BMI、心房和心室重构以及炎症标志物的增加可能是HFmrEF患者发生阵发性/持续性心房颤动的危险因素。此外,纤维化因子水平显著增加了这些患者发生持续性心房颤动的可能性。